SCM
BIOA

Saba Capital Management’s BioAmber Inc. BIOA Stock Holding History

Saba Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-98,882
Closed -$740K – 243
2013
Q4 		$740K Sell
98,882
-28,568
-22% -$196K 0.04% 168
2013
Q3 		$625K Hold
127,450
– – 0.05% 129
2013
Q2 		$867K Buy
+127,450
New +$948K 0.11% 73

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Saba Capital Management's BIOA Position: Q1 2014 in Review

Saba Capital Management sold out of BioAmber Inc. (BIOA) in Q1 2014, closing a stake of 98,882 shares — an estimated $740K sold.

Saba Capital Management first reported a position in BIOA in Q2 2013 and held it in 3 quarters. The position peaked at $867K in Q2 2013. 26 funds tracked by Wall St. Rank hold BIOA as of Q1 2014.

  • Saba Capital Management reported no remaining BioAmber Inc. position as of Q1 2014 after selling out during the quarter.
  • Saba Capital Management sold 98,882 BioAmber Inc. shares in Q1 2014, an estimated $740K.
  • Saba Capital Management first reported a position in BioAmber Inc. in Q2 2013 and held it in 3 quarters.
  • Saba Capital Management's BioAmber Inc. position peaked at $867K in Q2 2013.
  • 26 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2014.

Based on Saba Capital Management's 13F filing for Q1 2014, filed 15 May 2014.